No Detail Found!

Predicament in Detection and Reporting of Extended Spectrum Beta Lactamase Production in Routine Antibiotic Susceptibility Testing.

Author(s)
Tariq Butt Department of Microbiology, Foundation University Medical College and Fauji Foundation Hospital, Rawalpindi, Pakistan
Sania Raza Department of Microbiology, Foundation University Medical College and Fauji Foundation Hospital, Rawalpindi, Pakistan
Erum Butt Department of Microbiology, Foundation University Medical College and Fauji Foundation Hospital, Rawalpindi, Pakistan
Abstract
This descriptive and cross-sectional study was planned to determine the dilemma of inadvertent detection of extended spectrum beta lactamase (ESBL) production in Enterobacteriaceae when using inhibition zone size of antibiotic disks of Cefotaxime or Aztreonam in routine antibiotic susceptibility testing as recommended by Clinical Laboratory Standards Institute (CLSI). Screening and double disk tests were adopted as per CLSI. Escherichia coli ATCC 25922 was used as control strain. Among total specimens of 5346, there were 348 isolates of Escherichia coli (n=235), Klebsiella pneumonia (n=92), Klebsiella oxytoca (n=3) or Proteus mirabilus (n=18). The screening method recommended by CLSI significantly falsely detected ESBL production in 79 (32.3%) isolates (p<0.0001). ESBL detection is important as its frequency is high and treatment of the infection varies with the presence and absence of ESBL. To avoid false reporting, proper phenotypic detection of ESBL confirmatory method-like double-disk synergy test, should be used routinely.
Publication Details
Page(s) 788-790
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 27, Issue: 12, Year: 2017

Request the full text from PASTIC

Keywords
Extended spectrum beta lactamase. Detection. Double-disk synergy test. Screening test.
References
LeeNY,LeeCC,HuangWH,TsuiKC,HsuehPR,KoWC, 2013.Cefepime therapy for monomicrobial bacteraemia caused by cefepime-susceptible extended spectrum beta lactamase producing Enterobacteriaceae: MIC matters,Clin Infect Dis 56 488 -95
TammaPD,HanJH,RockC,HarrisAD,LantenbachE,HsuAJ, 2015.Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended spectrum -lactamase bacteraemia,Clin Infect Dis 60 1319 -25
PatelJB,CockerillFR,EliopoulosGM,JenkinsSG,LewisII JS,LimbagoB, 2016.M100S performance standards for antimicrobial susceptibility testing,Wayne PA: Clinical Laboratory Standards Institute 36 118 -21
AliAM,RafiS,QureshiAH, 2004.Frequency of extended spectrum beta lactamase producing gram-negative bacilli among clinical isolates at clinical laboratories of Army Medical College, Rawalpindi,J Ayub Med Coll Abbott bad 16 35 -7
GiriyapurRS,NandihalNW,KrishnaBVS,PatelAB,ChandrasekharMR, 2011.Comparison of disk diffusion methods for detection of extended spectrum beta lactamase producing Enterobacteriaceae,J Lab Physicians 3 33 -6
M'ZaliFH,ChanawongA,KerrKG,BirkenheadD,HawkeyePM, 2000.Detection of extended spectrum -lactamases in members of the family Enterobacteriaceae: comparison of the MAST DD test, the double disk and the Etest ESBL,J Antimicrob Chemother 45 881 -5
ThadenJT,FowlerVG,SextonDJ,AndersonDJ, 2016.Increasing incidence of extended spectrum -lactamase producing Escherichia coli in community hospitals throughout the Southeast United States,Infect Control Hosp Epidemiol 37 49 -54
0

Citations

0

Downloads

157

Views